Everest Medicines Limited (1952.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Everest Medicines Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -37.32x |
| P/B Ratio | 2.09x |
| P/S Ratio | 6.51x |
| Profitability | |
| Gross Margin | 69.2% |
| Operating Margin | -22.6% |
| Net Margin | -17.4% |
| EBITDA Margin | -12.4% |
| Liquidity | |
| Current Ratio | 4.89x |
| Quick Ratio | 4.77x |
| Leverage | |
| Debt/Equity | 0.17x |
YoY = year-over-year change. Source: FMP..